View Older Stories
-
Agilent (A) Reiterated at Buy by Stifel After Beat-and-Raise Quarter
-
Agilent (A) PT Lowered to $160 at Wells Fargo
-
Agilent (A) PT Raised to $170 at Leerink
-
BofA Securities Upgrades Agilent (A) to Buy
-
Agilent Technologies (A) Tops Q2 EPS by 8c; offers guidance
-
RBC Capital Starts Agilent (A) at Outperform
-
Agilent launches 8890B and 8860B gas chromatographs with GC Assist
-
Agilent launches 9500 ICP-MS system for trace element analysis
-
Agilent Technologies (A) Declares $0.255 Quarterly Dividend; 0.9% Yield
-
Agilent wins TSA contract for airport security tech ahead of 2026 World Cup
-
Agilent launches BioTek Cytation 9 cell imaging multimode reader
-
Agilent launches unified CDMO division across Canada and United States
-
Citi Opens Catalyst Watch on Agilent Technologies (A)
-
BofA Securities Reiterates Neutral Rating on Agilent (A) following Biocare Medical acquisition announcement
-
Agilent VP Rodney Gonsalves to retire as controller in January 2027
-
Agilent (A) PT Lowered to $160 at Morgan Stanley
-
Agilent Technologies shares fall after Q1 earnings miss
-
Agilent Technologies (A) Misses Q1 EPS by 1c; offers guidance
-
Agilent Technologies (A) Declares $0.255 Quarterly Dividend; 0.8% Yield
-
Agilent launches S540MD slide scanner system in European markets
-
HSBC Starts Agilent (A) at Buy
-
UBS Reiterates Buy Rating on Agilent (A) on Multiple Expansion Potential Vs Peers
-
TORM appoints Simon Mackenzie Smith as board chair
-
Barclays Upgrades Agilent (A) to Overweight
-
Goldman Sachs starts Life Sciences Tools coverage, rates these 3 stocks at Buy
-
Goldman Sachs Starts Agilent (A) at Buy
-
Morgan Stanley Starts Agilent (A) at Overweight, 'Bullish on Strategic Initiatives'
-
Agilent (A) PT Raised to $170 at Stifel
-
Agilent (A) PT Raised to $180 at UBS on Multiple Drivers of Long-Term Growth
-
Agilent (A) PT Raised to $165 at Leerink Partners
-
BofA Securities Reiterates Neutral Rating on Agilent (A)
-
Agilent (A) PT Raised to $155 at Evercore ISI
-
After-hours movers: Zoom, Agilent, Symbotic
-
Agilent Technologies (A) Tops Q4 EPS by 1c, Beats on Revenue; Offers FY26 Guidance
-
Agilent Technologies (A) call put ratio 1 call to 1.8 puts into quarter results today
-
Agilent Technologies (A) call put ratio 1 call to 1.9 puts into quarter results
-
Agilent Technologies (A) call put ratio 2.3 calls to 1 put into quarter results
-
Agilent Technologies (A) Declares $0.255 Quarterly Dividend; 0.7% Yield
-
Rothschild Redburn Starts Agilent (A) at Buy
-
UBS Upgrades Agilent (A) to Buy
-
Agilent (A) PT Raised to $130 at Jefferies
-
Agilent launches Altura HPLC columns for biotherapeutic testing
-
Lunit partners with Agilent to develop AI companion diagnostic tools
-
Agilent Technologies (A) Declares $0.248 Quarterly Dividend; 0.8% Yield
-
TD Cowen: 'Agilent (A) Picking Up Where a Strong F3Q Left Off'
-
Agilent receives European certification for colorectal cancer diagnostic
-
KeyBanc Reiterates Sector Weight Rating on Agilent (A)
-
TD Cowen Reiterates Buy Rating on Agilent (A)
-
Bernstein on Agilent (A): 'Strong Organic Growth Shows Continued Market Recovery'
-
Agilent (A) PT Raised to $140 at Leerink Partners

